Evidence on the effects of phentermine-topiramate extended-release (ER) on the kidney is insufficient, but the use of phentermine or topiramate
ITT, intention-to-treat; LOCF, last observation carried forward; LS, least squares; PHEN/TPM ER 15/92, phentermine 15 mg and topiramate extended-release 92 mg; PHEN 15, phentermine 15 mg; TPM ER 92, topiramate extended-release 92 mg; PHEN/TPM ER 7.5/46, phentermine 7.5 mg/topiramate extended-release 46 mg; PHEN 7.5, phentermine 7.5 mg; TPM ER
Evidence on the effects of phentermine-topiramate extended-release (ER) on the kidney is insufficient, but the use of phentermine or topiramate
Phentermine-topiramate (Qsymia). Topiramate can be combined with Semaglutide. Liraglutide. Phentermine-topiramate extended-release (ER).
by JK Joo 2024 Cited by 56Phentermine/Topiramate Extended-release (ER) (Qsymia) Qsymia is the combination of phentermine and topiramate as an ER medication (Vivus Inc
combination of the weight-loss drug phentermine and an extended-release (ER) formulation of topiramate .
by ER Yoo 2024 Cited by 12Phentermine, diethylpropion, benzphetamine, and phendimetrazine are phentermine and topiramate versus phentermine/topiramate extended-release
Phentermine and topiramate extended-release (phentermine/topiramate ER) has recently been approved in the USA for chronic weight management in obese adults
A Review of the Combination of Phentermine and Topiramate Extended-Release for Weight Loss release phentermine/ topiramate (PHN/TPM ER) in obese patients.
months. Great start. Let’s get er done.